cmRNAbone

3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Programme
Horizon 2020 & sub-programmes
Duration
54 months (January 2020 – June 2024)
Project funding
≈ €6 million
Project partners
11
Technology readiness level
4-7

What the project is about

The cmRNAbone project aim to create a novel bone regenerative therapeutic approach based on combination of chemically modified RNAs (cmRNAs)-vectors embedded in a 3D-printed guiding biomaterial ink tailored to patients need.

Coordinator

Prof. Martin Stoddart

AO Research Institute Davos, Switzerland

Email coordinator

Your EURICE
contact

Your contact
Nadine Drechoux
Senior Research & Impact Manager
E-mail

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

Enter THE COURT